These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 31449776
1. Repression of Death Receptor-Mediated Apoptosis of Hepatocytes by Hepatitis B Virus e Antigen. Liu W, Guo TF, Jing ZT, Tong QY. Am J Pathol; 2019 Nov; 189(11):2181-2195. PubMed ID: 31449776 [Abstract] [Full Text] [Related]
2. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. Liu W, Lin YT, Yan XL, Ding YL, Wu YL, Chen WN, Lin X. FASEB J; 2015 Mar; 29(3):1113-23. PubMed ID: 25466893 [Abstract] [Full Text] [Related]
3. Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation. Jing ZT, Liu W, Wu SX, He Y, Lin YT, Chen WN, Lin XJ, Lin X. J Immunol; 2018 Oct 15; 201(8):2303-2314. PubMed ID: 30171166 [Abstract] [Full Text] [Related]
4. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, Zhang L, Chen YH, Sun W. J Immunol; 2007 Jan 01; 178(1):503-10. PubMed ID: 17182590 [Abstract] [Full Text] [Related]
5. Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling. Wu SX, Chen WN, Jing ZT, Liu W, Lin XJ, Lin X. J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30209179 [Abstract] [Full Text] [Related]
6. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Zou C, Chen J, Chen K, Wang S, Cao Y, Zhang J, Sheng Y, Huang A, Tang H. Exp Cell Res; 2015 Feb 15; 331(2):352-61. PubMed ID: 25449696 [Abstract] [Full Text] [Related]
7. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H. Cell Death Differ; 2004 Jul 15; 11 Suppl 1():S86-96. PubMed ID: 15105837 [Abstract] [Full Text] [Related]
9. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype. Xia Y, Cheng X, Li Y, Valdez K, Chen W, Liang TJ. J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021897 [Abstract] [Full Text] [Related]
10. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. Hum Pathol; 2005 Oct 01; 36(10):1066-73. PubMed ID: 16226105 [Abstract] [Full Text] [Related]
11. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Du J, Liang X, Liu Y, Qu Z, Gao L, Han L, Liu S, Cui M, Shi Y, Zhang Z, Yu L, Cao L, Ma C, Zhang L, Chen Y, Sun W. Cell Death Differ; 2009 Feb 01; 16(2):219-29. PubMed ID: 18927587 [Abstract] [Full Text] [Related]
12. Involvement of TRAIL and its receptors in viral hepatitis. Mundt B, Kühnel F, Zender L, Paul Y, Tillmann H, Trautwein C, Manns MP, Kubicka S. FASEB J; 2003 Jan 01; 17(1):94-6. PubMed ID: 12475902 [Abstract] [Full Text] [Related]
13. Modulation of death receptor pathways in oncology. de Vries EG, Timmer T, Mulder NH, van Geelen CM, van der Graaf WT, Spierings DC, de Hooge MN, Gietema JA, de Jong S. Drugs Today (Barc); 2003 Jan 01; 39 Suppl C():95-109. PubMed ID: 14988748 [Abstract] [Full Text] [Related]
14. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. Milich DR, Chen MK, Hughes JL, Jones JE. J Immunol; 1998 Feb 15; 160(4):2013-21. PubMed ID: 9469465 [Abstract] [Full Text] [Related]
15. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin. Li J, Dai X, Zhang H, Zhang W, Sun S, Gao T, Kou Z, Yu H, Guo Y, Du L, Jiang S, Zhang J, Zhou Y. Oncotarget; 2015 Oct 06; 6(30):29196-208. PubMed ID: 26470691 [Abstract] [Full Text] [Related]
16. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO. Wang Y, Cui L, Yang G, Zhan J, Guo L, Chen Y, Fan C, Liu D, Guo D. J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30404796 [Abstract] [Full Text] [Related]
17. Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B. Zheng NQ, Zheng ZH, Xu HX, Huang MX, Peng XM. Virol J; 2017 Apr 13; 14(1):77. PubMed ID: 28407787 [Abstract] [Full Text] [Related]
18. Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. Jia B, Guo M, Li G, Yu D, Zhang X, Lan K, Deng Q. J Virol; 2015 Feb 13; 89(4):2041-51. PubMed ID: 25428880 [Abstract] [Full Text] [Related]
19. Harmonized Autophagy Versus Full-Fledged Hepatitis B Virus: Victorious or Defeated. Abdoli A, Nakhaie M, Feizi N, Salimi Jeda A, Ramezani A. Viral Immunol; 2019 Oct 13; 32(8):322-334. PubMed ID: 31483214 [Abstract] [Full Text] [Related]
20. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. Kim SY, Kim JK, Kim HJ, Ahn JK. IUBMB Life; 2005 Sep 13; 57(9):651-8. PubMed ID: 16203685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]